- Amneal Pharmaceuticals ( NYSE: AMRX ) is scheduled to announce Q3 earnings results on Friday, November 4th, before market open.
- The consensus EPS Estimate is $0.18 (-14.3% Y/Y) and the consensus Revenue Estimate is $562.17M (+6.3% Y/Y).
- Over the last 2 years, AMRX has beaten EPS estimates 63% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 7 downward. Revenue estimates have seen 4 upward revisions and 1 downward.
For further details see:
Amneal Pharmaceuticals Q3 2022 Earnings Preview